Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Br J Anaesth. 2022 Jun;128(6):1029-1039. doi: 10.1016/j.bja.2022.03.009. Epub 2022 Apr 14.
There are very few patient-centred global outcome measures of recovery in the days or weeks after surgery. This meta-analysis evaluated the psychometric properties and clinical acceptability of the 15-item quality of recovery (QoR-15) scale.
We searched bibliographic databases for studies undertaking psychometric evaluation of the QoR-15 or using the QoR-15 as an outcome measure after surgery. Record screening, data extraction, and quality assessments were independently done by two researchers. Weighted averages estimating overall summary statistics across all the studies were calculated using random-effects meta-analysis. Pooled correlation coefficients were transformed using a Fisher z-transformation and then back-transformed to calculate pooled results. The four co-primary endpoints were validity, reliability, responsiveness, and clinical utility of the QoR-15 scale.
A total of 26 unique studies met the eligibility criteria, yielding up to 22 847 patients across 16 countries, in 15 languages. A further 172 studies in a further 18 countries and six languages used the QoR-15 as an outcome measure. The QoR-15 had excellent discriminant validity, with the mean difference in QoR-15 scores in patients with and without postoperative complications (9.6; 95% confidence interval [CI], 5.9-13.3; P<0.001), and good convergent validity (for a global visual analogue recovery scale, pooled r=0.63; 95% CI, 0.54-0.71). There was excellent reliability: internal consistency (pooled α=0.85; 95% CI, 0.83-0.87), split-half reliability=0.80 (95% CI, 0.75-0.84), and test-retest reliability=0.97 (95% CI, 0.95-0.98). There was also high responsiveness (pooled standardised response mean=0.87; 95% CI, 0.65-1.08), patient recruitment into evaluation studies (96%; 95% CI, 93-99), and excellent completion and return rates (91%; 95% CI, 84-96). The mean time to complete the QoR-15 was 2.7 (95% CI, 2.2-3.1) min.
The QoR-15 is a valid, reliable, and responsive patient-centred outcome metric in surgical patients. It is highly acceptable to both patients and clinicians.
Open Science Framework Identifier: DOI 10.17605/OSF.IO/78HTA.
在手术后的几天或几周内,很少有以患者为中心的全球康复结局测量方法。本荟萃分析评估了 15 项康复质量(QoR-15)量表的心理测量特性和临床可接受性。
我们在文献数据库中检索了对 QoR-15 进行心理测量评估或在手术后使用 QoR-15 作为结局测量的研究。记录筛选、数据提取和质量评估由两名研究人员独立进行。使用随机效应荟萃分析计算了所有研究的加权平均值,以估计总体汇总统计数据。使用 Fisher z 变换转换了汇总相关系数,然后进行逆变换以计算汇总结果。四个主要终点是 QoR-15 量表的有效性、可靠性、反应性和临床实用性。
共有 26 项符合纳入标准的研究,来自 16 个国家的 22847 名患者,涉及 15 种语言。另外,在 18 个国家和 6 种语言中有 172 项研究使用 QoR-15 作为结局测量。QoR-15 具有极好的判别效度,有术后并发症和无术后并发症患者的 QoR-15 评分差值为 9.6(95%置信区间[CI],5.9-13.3;P<0.001),且有较好的收敛效度(与全球视觉模拟恢复量表相比,汇总 r=0.63;95%CI,0.54-0.71)。信度极好:内部一致性(汇总α=0.85;95%CI,0.83-0.87),半分信度=0.80(95%CI,0.75-0.84),重测信度=0.97(95%CI,0.95-0.98)。反应性也很高(汇总标准化反应均值=0.87;95%CI,0.65-1.08),患者入组评估研究的比例为 96%(95%CI,93-99),完成和返回率很高(91%;95%CI,84-96)。完成 QoR-15 量表的平均时间为 2.7 分钟(95%CI,2.2-3.1)。
QoR-15 是一种有效的、可靠的、以患者为中心的手术患者结局衡量指标,对患者和临床医生均具有高度可接受性。
开放科学框架标识符:DOI 10.17605/OSF.IO/78HTA。